CD8A and neoplasm: Cyclic dimeric guanosine monophosphate (c-di-GMP), a STING agonist, initiates a type I interferon (IFN-I) response, which causes CD8+ T cells to accumulate and infiltrate at the tumor sites and triggers an immunogenic response [144,145].